Study of GPX-100 in the Treatment of Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastasis
Interventions: DRUG: GPX-100 (13-deoxydoxorubicin)
Sponsor: Gem Pharmaceuticals